Novo Holdings Venture Investments 2023 Newsletter: A record year advancing innovative therapies for patients
- 18 new portfolio investments
- Five portfolio companies acquired
- $766 million invested and committed
- $600 million of cash exit proceeds
San Francisco, Boston, London, and Copenhagen, Denmark, 5 March 2024 – The Novo Holdings Venture Investments team today published its review of 2023 – a record year advancing innovative therapies for patients.
